Tag: Skin Biopsy Market Growth

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Skin Biopsy Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?

The skin biopsy market size has demonstrated robust growth in recent years. It is projected to increase from $1.86 billion in 2025 to $2.02 billion in 2026, at a compound annual growth rate (CAGR) of 8.3%. This historical expansion can be attributed to an escalation in skin cancer incidence, the proliferation of dermatology clinics, the adoption of outpatient diagnostics, the widespread availability of biopsy instruments, and enhanced awareness regarding early diagnosis.

The skin biopsy market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the projection period include an increase in melanoma incidents, the embrace of AI-powered diagnostics, the broadening scope of tele-dermatology, an aging global demographic, and the expansion of cosmetic dermatology services. Key developments expected within this forecast timeframe encompass the adoption of less invasive biopsy methods, a wider application of dermatological diagnostics, a preference for punch and shave biopsy techniques, a shift towards outpatient diagnostic procedures, and the integration of AI in pathology.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=36719869&type=smp&name=Skin%20Biopsy%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Skin Biopsy Market Growth Backed By Core Demand Fundamentals

The skin biopsy market is anticipated to experience growth in the future, driven by increasing healthcare expenditure. This spending encompasses the total funds allocated to medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or enhancing health outcomes. The heightened need for healthcare funding is a result of the growing prevalence of chronic diseases, which often require extensive and costly treatments. Elevated healthcare expenditure contributes to greater adoption of skin biopsies by improving access to advanced diagnostic technologies and expanding dermatology services. This enables prompt detection and precise diagnosis of skin disorders, thereby supporting better patient outcomes and overall healthcare efficiency. As an example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure in 2023 rose by 5.6% in nominal terms, indicating a 0.9% increase in growth when compared to 2022. Consequently, the rising healthcare expenditure is a key factor propelling the expansion of the skin biopsy market.

Skin Biopsy Market Segment Performance And Emerging Opportunities

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

Skin Biopsy Market Growth Trends Reshaping The Competitive Landscape

Companies active in the skin biopsy market are concentrating on creating advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic accuracy and the caliber of tissue samples. Semi-automatic biopsy instruments are specifically designed to ensure controlled and precise tissue gathering, thereby enhancing the likelihood of an accurate diagnosis and enabling pathologists to carry out thorough testing. For instance, in May 2023, Argon Medical Devices, a US-based provider of interventional and oncology device solutions, unveiled the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers excellent tissue volume and is available across a full spectrum of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, conceptualized with input from healthcare professionals to fulfill clinical needs. The SuperCore Advantage empowers physicians to collect more tissue with confidence, facilitates precise and reliable biopsies, and complements Argon’s current portfolio, including the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This addition bolsters Argon’s position as a prominent supplier of soft tissue biopsy devices while simultaneously improving patient outcomes.

Skin Biopsy Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

View The Full Skin Biopsy Market Report:

https://thebusinessresearchcompany.com/report/skin-biopsy-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Skin Biopsy Market Regional Outlook: Where Is Opportunity Concentrated?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The skin biopsy market is witnessing rapid advancements driven by rising skin cancer cases and evolving diagnostic technologies. As awareness of early detection grows and healthcare infrastructure improves, this sector is set for sustained expansion. Below is an overview of the market’s current size, growth drivers, segmentation, innovation trends, key players, and regional outlook.

Market Size and Growth Trajectory of the Skin Biopsy Market

The skin biopsy market has demonstrated robust growth in recent years. It is projected to increase from $1.86 billion in 2025 to $2.02 billion in 2026, marking a compound annual growth rate (CAGR) of 8.3%. Historical growth has been propelled by a rise in skin cancer incidence, expansion of dermatology clinics, greater adoption of outpatient diagnostic procedures, availability of biopsy instruments, and heightened awareness about early diagnosis. Looking ahead, the market is expected to reach $2.74 billion by 2030, maintaining a healthy CAGR of 8.0%. This anticipated growth is driven by the rising number of melanoma cases, incorporation of AI-powered diagnostic tools, growth of tele-dermatology services, an aging global population, and an increase in cosmetic dermatology procedures. Notable trends include the preference for minimally invasive biopsy methods, expansion in dermatology diagnostics, and wider acceptance of punch and shave biopsies alongside outpatient diagnostic techniques and AI-assisted pathology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Key Factors Boosting Growth in the Skin Biopsy Market

Increasing healthcare expenditure is playing a vital role in expanding the skin biopsy market. This spending encompasses investments in medical treatments, diagnostic technologies, research, and public health efforts aimed at improving patient outcomes. The growing burden of chronic diseases, which require long-term and costly management, is a significant contributor to rising healthcare costs. Enhanced healthcare budgets improve access to advanced biopsy technologies and broaden dermatology services, supporting early and accurate diagnosis of skin conditions. For example, in May 2024, the UK’s Office for National Statistics reported a 5.6% nominal increase in total healthcare expenditure for 2023, representing a 0.9% growth compared to 2022. This upward trend in healthcare funding underpins the expansion of the skin biopsy market.

Additional Drivers Supporting Skin Biopsy Market Growth

Another important factor fueling market growth is the increasing incidence of skin cancers worldwide, particularly melanoma. Early and precise biopsy techniques are essential for effective treatment planning and improved patient prognosis. The advent of AI-enabled diagnostics and tele-dermatology is revolutionizing how skin biopsies are performed, allowing for faster, more accurate evaluations and remote consultations. Furthermore, demographic shifts such as an aging population with higher susceptibility to skin disorders and the rising demand for cosmetic dermatology procedures continue to drive the need for advanced biopsy tools and services.

Access The Complete Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Detailed Breakdown of Skin Biopsy Market Segments

This market is categorized into different segments based on biopsy type, application, and end-user. By biopsy type, it includes excisional biopsy (subdivided into full-thickness and elliptical excision), incisional biopsy (wedge, longitudinal, and keyhole biopsy), punch biopsy (with sizes of 2 mm, 3-4 mm, and equal to or greater than 5 mm), and shave biopsy (including tangential, saucerization, and curved blade shave). On the application front, the market covers dermatology, oncology, and clinical research. Regarding end-users, hospitals, ambulatory surgical centers (ASCs), and dermatology clinics form the main categories.

Innovations Driving Transformation Within the Skin Biopsy Market

Leading companies in this sector are focusing on developing cutting-edge biopsy instruments that enhance diagnostic precision and improve tissue sample quality. Semi-automatic biopsy devices are gaining popularity as they provide more controlled and accurate tissue collection, facilitating reliable diagnoses and comprehensive pathological analysis. For example, in May 2023, Argon Medical Devices, a US-based provider specializing in interventional and oncology solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This disposable, next-generation device offers superior tissue volume and comes in various lengths and gauge sizes to suit diverse clinical needs. Designed with input from healthcare professionals, it enables physicians to confidently collect larger tissue samples. The SuperCore Advantage complements Argon’s existing portfolio, which includes instruments like the BioPince Ultra Full Core Biopsy, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments, solidifying the company’s leadership in soft tissue biopsy solutions while improving patient outcomes.

Prominent Players Holding Strong Positions in the Skin Biopsy Market

Several notable companies lead the skin biopsy market with their extensive product offerings and innovation capabilities. These include AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, and Integra Miltex.

Regional Overview and Market Leadership

In 2025, North America held the largest share of the skin biopsy market, driven by well-established healthcare infrastructure and high adoption of advanced diagnostic tools. Meanwhile, Asia-Pacific is expected to be the fastest-growing region during the forecast period, propelled by increasing healthcare investments, rising skin cancer incidence, and expanding dermatology services. The market analysis encompasses key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Skin Biopsy Market By 2030?

The skin biopsy market has experienced significant growth in recent years. It is projected to expand from $1.86 billion in 2025 to $2.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. This historical development can be attributed to an increase in skin cancer incidence, the expansion of dermatology clinics, the adoption of outpatient diagnostics, the widespread availability of biopsy instruments, and a greater awareness of early diagnosis.

The skin biopsy market size is expected to experience significant growth in the upcoming years. It is forecast to grow to $2.74 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.0%. This expansion during the forecast period is attributed to the increasing instances of melanoma, the growing adoption of AI-enabled diagnostics, the broader reach of tele-dermatology, the aging global population, and the growth witnessed in cosmetic dermatology. Key trends for the forecast period include the rise of minimally invasive biopsy techniques, an expansion in dermatology diagnostics, a preference for punch and shave biopsies, the increasing number of outpatient diagnostic procedures, and the integration of AI-assisted pathology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Which Core Factors Are Supporting The Expansion Of The Skin Biopsy Market?

Increasing Healthcare Spending Drives Growth in the Skin Biopsy Market Growing healthcare expenditure is anticipated to support the expansion of the skin biopsy market in the coming years. Healthcare expenditure encompasses the overall spending on medical services, treatments, healthcare infrastructure, research activities, and public health programs aimed at improving health outcomes. The rise in healthcare spending is primarily linked to the increasing incidence of chronic diseases that demand ongoing and expensive medical care. Higher healthcare investments are encouraging the adoption of skin biopsy procedures by improving access to advanced diagnostic technologies and broadening dermatology-related services. This facilitates early detection and precise diagnosis of skin conditions, contributing to improved patient care and greater healthcare efficiency. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing 0.9% higher growth compared to 2022. Therefore, increasing healthcare expenditure is fueling the growth of the skin biopsy market.

What Are The Major Segment Categories Within The Skin Biopsy Market?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (≥) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

What Trends Are Affecting The Skin Biopsy Market Dynamics?

Leading companies in the skin biopsy market are concentrating on developing advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic accuracy and the quality of tissue samples. These semi-automatic instruments are engineered to facilitate controlled and precise tissue collection, thereby increasing the likelihood of an accurate diagnosis and enabling pathologists to conduct comprehensive tests. For example, in May 2023, Argon Medical Devices, a US-based company supplying interventional and oncology device solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers a superior volume of tissue and is available in a complete array of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, designed with insights from healthcare professionals to meet clinical needs. The SuperCore Advantage enables physicians to confidently collect more tissue, supports precise and reliable biopsies, and complements Argon’s existing product range, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This introduction solidifies Argon’s position as a key provider of soft tissue biopsy devices while simultaneously enhancing outcomes for patients.

Who Are The Companies Shaping The Skin Biopsy Market Landscape?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Access The Complete Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Is The Primary Market For The Skin Biopsy Market?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Skin Biopsy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Skin Biopsy Market By 2030?

The skin biopsy market has experienced significant growth in recent years. It is projected to expand from $1.86 billion in 2025 to $2.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. This historical development can be attributed to an increase in skin cancer incidence, the expansion of dermatology clinics, the adoption of outpatient diagnostics, the widespread availability of biopsy instruments, and a greater awareness of early diagnosis.

The skin biopsy market size is expected to experience significant growth in the upcoming years. It is forecast to grow to $2.74 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.0%. This expansion during the forecast period is attributed to the increasing instances of melanoma, the growing adoption of AI-enabled diagnostics, the broader reach of tele-dermatology, the aging global population, and the growth witnessed in cosmetic dermatology. Key trends for the forecast period include the rise of minimally invasive biopsy techniques, an expansion in dermatology diagnostics, a preference for punch and shave biopsies, the increasing number of outpatient diagnostic procedures, and the integration of AI-assisted pathology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Which Core Factors Are Supporting The Expansion Of The Skin Biopsy Market?

Increasing Healthcare Spending Drives Growth in the Skin Biopsy Market Growing healthcare expenditure is anticipated to support the expansion of the skin biopsy market in the coming years. Healthcare expenditure encompasses the overall spending on medical services, treatments, healthcare infrastructure, research activities, and public health programs aimed at improving health outcomes. The rise in healthcare spending is primarily linked to the increasing incidence of chronic diseases that demand ongoing and expensive medical care. Higher healthcare investments are encouraging the adoption of skin biopsy procedures by improving access to advanced diagnostic technologies and broadening dermatology-related services. This facilitates early detection and precise diagnosis of skin conditions, contributing to improved patient care and greater healthcare efficiency. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing 0.9% higher growth compared to 2022. Therefore, increasing healthcare expenditure is fueling the growth of the skin biopsy market.

What Are The Major Segment Categories Within The Skin Biopsy Market?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (≥) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

What Trends Are Affecting The Skin Biopsy Market Dynamics?

Leading companies in the skin biopsy market are concentrating on developing advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic accuracy and the quality of tissue samples. These semi-automatic instruments are engineered to facilitate controlled and precise tissue collection, thereby increasing the likelihood of an accurate diagnosis and enabling pathologists to conduct comprehensive tests. For example, in May 2023, Argon Medical Devices, a US-based company supplying interventional and oncology device solutions, introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers a superior volume of tissue and is available in a complete array of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, designed with insights from healthcare professionals to meet clinical needs. The SuperCore Advantage enables physicians to confidently collect more tissue, supports precise and reliable biopsies, and complements Argon’s existing product range, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This introduction solidifies Argon’s position as a key provider of soft tissue biopsy devices while simultaneously enhancing outcomes for patients.

Who Are The Companies Shaping The Skin Biopsy Market Landscape?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Access The Complete Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Is The Primary Market For The Skin Biopsy Market?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Skin Biopsy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Skin Biopsy Market Over The 2026–2030 Period?

The skin biopsy market has experienced robust expansion in recent years. This market is projected to expand from $1.86 billion in 2025 to $2.02 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this growth has been driven by factors such as a rise in skin cancer cases, the proliferation of dermatology clinics, the embrace of outpatient diagnostic procedures, the accessibility of biopsy tools, and increased understanding of the importance of early diagnosis.

The skin biopsy market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. Several factors are driving this expansion during the forecast period, including an increase in melanoma diagnoses, the growing integration of AI-enabled diagnostic tools, the broadening scope of tele-dermatology services, the demographic shift towards an aging population, and the continuous growth within cosmetic dermatology. Key trends observed within the forecast period encompass the development of minimally invasive biopsy methods, the overall expansion of dermatology diagnostics, a continued preference for punch and shave biopsy techniques, the increasing prevalence of outpatient diagnostic procedures, and the integration of AI-assisted pathology.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Skin Biopsy Market?

The increasing healthcare expenditure is projected to stimulate the expansion of the skin biopsy market moving forward. Healthcare expenditure is defined as the total financial outlay on medical services, treatments, facilities, research, and public health programs aimed at maintaining or improving health outcomes. The escalating demand for healthcare spending stems from the rising prevalence of chronic diseases, which necessitate long-term and costly treatments. Enhanced healthcare expenditure boosts the adoption of skin biopsy by improving access to advanced diagnostic technologies and expanding dermatology services. This facilitates the early detection and accurate diagnosis of skin disorders, leading to improved patient outcomes and overall healthcare efficiency. For instance, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure experienced a 5.6% increase in nominal terms in 2023, which signifies a 0.9% growth compared to 2022. Therefore, the upward trend in healthcare expenditure is a primary driver for the growth of the skin biopsy market.

How Is The Skin Biopsy Market Segmented Across Different Segment Categories?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (≥) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

Which Trends Are Shaping The Skin Biopsy Market?

Leading companies operating within the skin biopsy market are concentrating on developing advanced solutions, such as semi-automatic biopsy instruments, to improve diagnostic precision and the quality of tissue samples. These semi-automatic devices are engineered to ensure controlled and precise tissue collection, thereby increasing the likelihood of an accurate diagnosis and enabling pathologists to conduct comprehensive testing. For example, in May 2023, Argon Medical Devices, a US-based provider of interventional and oncology device solutions, launched its SuperCore Advantage Semi-Automatic Biopsy Instrument. This instrument provides superior tissue volume and is offered in a complete range of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, designed with input from healthcare professionals to meet clinical needs. The SuperCore Advantage allows physicians to confidently collect more tissue, supports precise and reliable biopsies, and complements Argon’s existing portfolio, including the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This introduction strengthens Argon’s position as a prominent provider of soft tissue biopsy devices while simultaneously enhancing outcomes for patients.

Which Organizations Play A Role In The Skin Biopsy Market Landscape?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Get The Full Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Is The Top Contributor To The Skin Biopsy Market By Share?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Skin Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Skin Biopsy Market Expected To Change Between 2026 And 2030?

The skin biopsy market has shown robust growth over recent years. It is forecast to increase from $1.86 billion in 2025 to $2.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. This historical expansion can be attributed to a rise in skin cancer incidence, the proliferation of dermatology clinics, the adoption of outpatient diagnostic methods, the availability of biopsy instruments, and improved awareness of early diagnosis.

The skin biopsy market is anticipated to experience substantial expansion in the coming years, set to reach $2.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period is propelled by factors such as a rise in melanoma incidents, the embrace of AI-powered diagnostics, the increasing presence of tele-dermatology, an aging population, and the expansion within cosmetic dermatology. Prominent trends for this period encompass the adoption of minimally invasive biopsy methods, the broadening scope of dermatology diagnostics, a preference for punch and shave biopsy techniques, the shift towards outpatient diagnostic procedures, and the incorporation of AI-assisted pathology.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Which Major Factors Are Driving The Expansion Of The Skin Biopsy Market?

An anticipated surge in healthcare spending is poised to drive the expansion of the skin biopsy market in the foreseeable future. Healthcare expenditure encompasses the aggregate financial outlay directed towards medical services, therapies, infrastructure, research, and public health efforts aimed at preserving or elevating health outcomes. This growing demand for healthcare funding stems from the increasing incidence of chronic illnesses, which necessitate prolonged and expensive medical interventions. Greater healthcare spending facilitates the uptake of skin biopsies by improving access to sophisticated diagnostic tools and broadening the scope of dermatology services. This, in turn, allows for prompt detection and precise diagnosis of skin conditions, contributing to superior patient results and enhanced overall healthcare effectiveness. For illustration, the Office for National Statistics, a UK-based government department, reported in May 2024 that the total healthcare expenditure experienced a 5.6% rise in nominal terms during 2023, representing a 0.9% growth compared to 2022. Consequently, the upward trend in healthcare expenditure is a key factor propelling the expansion of the skin biopsy market.

How Is The Skin Biopsy Market Structured Across Different Segments?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

Which Trends Are Shaping The Future Of The Skin Biopsy Market?

Major companies within the skin biopsy market are prioritizing the development of advanced solutions like semi-automatic biopsy instruments to improve diagnostic accuracy and the quality of tissue samples. Semi-automatic biopsy devices are engineered to provide precise and controlled tissue collection, thereby increasing the likelihood of an accurate diagnosis and enabling pathologists to conduct comprehensive testing. For instance, in May 2023, Argon Medical Devices, a U.S.-based provider of interventional and oncology device solutions, introduced its SuperCore Advantage Semi-Automatic Biopsy Instrument. This device delivers enhanced tissue volume and is available in a full range of lengths and gauge sizes to suit various clinical applications. It is a disposable, next-generation product, designed with input from healthcare professionals to address clinical needs. The SuperCore Advantage enables physicians to confidently collect more tissue, supports precise and reliable biopsies, and complements Argon’s existing portfolio, which includes the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This addition strengthens Argon’s position as a leading provider of soft tissue biopsy devices while also enhancing outcomes for patients.

Which Major Players Dominate The Skin Biopsy Market?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Read the full skin biopsy market report here:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Currently Holds The Largest Share Of The Skin Biopsy Market?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Skin Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28330&type=smp

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Skin Biopsy Market covering 2026–2035?

The skin biopsy market has witnessed robust expansion in recent times. This market is set to increase from $1.86 billion in 2025 to $2.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. The historical growth of this market is attributable to a surge in skin cancer prevalence, the proliferation of dermatology clinics, the widespread adoption of outpatient diagnostics, the ready availability of biopsy instruments, and an increased understanding of the importance of early diagnosis.

The skin biopsy market size is anticipated to experience substantial expansion over the next few years, with projections indicating a rise to $2.74 billion by 2030, supported by a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period is primarily driven by factors such as an increase in melanoma cases, the adoption of AI-enabled diagnostics, the broader expansion of tele-dermatology, the influence of an aging population, and the ongoing growth in cosmetic dermatology. Concurrently, major trends expected to shape the market include the increasing use of minimally invasive biopsy techniques, the expansion of dermatology diagnostic capabilities, a continued preference for punch and shave biopsy, the prevalence of outpatient diagnostic procedures, and the integration of AI-assisted pathology.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Skin Biopsy Market?

The future expansion of the skin biopsy market is anticipated to be driven by increasing healthcare spending. Healthcare expenditure encompasses the entire sum allocated to medical services, treatments, facilities, research, and public health initiatives aimed at maintaining or enhancing health outcomes. The growing need for healthcare funding stems from the increasing occurrence of chronic diseases, which necessitate prolonged and expensive care. Elevated healthcare spending boosts the adoption of skin biopsy procedures by making advanced diagnostic technologies more accessible and expanding dermatology services. This facilitates the early and precise identification of skin conditions, leading to improved patient results and greater overall healthcare efficiency. As an example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure experienced a 5.6% rise in nominal terms in 2023, representing a 0.9% growth from 2022. Consequently, the expanding healthcare expenditure is fueling the growth of the skin biopsy market.

What Leading Segments Are Studied In The Skin Biopsy Market?

The skin biopsy market covered in this report is segmented –

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy

2) By Application: Dermatology, Oncology, Clinical Research

3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

What Upcoming Trends Are Likely To Define The Future Path Of The Skin Biopsy Market?

Leading firms in the skin biopsy market are prioritizing the creation of advanced solutions, like semi-automatic biopsy instruments, aiming to improve both diagnostic precision and the caliber of tissue samples. These instruments are engineered for precise and controlled tissue gathering, thereby increasing the probability of correct diagnoses and allowing pathologists to conduct thorough examinations. An example of this is the launch of the SuperCore Advantage Semi-Automatic Biopsy Instrument by Argon Medical Devices, a US-based provider of interventional and oncology device solutions, in May 2023. This particular device offers enhanced tissue volume and comes in a complete selection of lengths and gauge sizes, suitable for diverse clinical uses. It is a disposable, next-generation tool, developed with contributions from healthcare professionals to address specific clinical requirements. The SuperCore Advantage enables physicians to confidently gather more tissue, facilitates accurate and dependable biopsies, and augments Argon’s current product line, which features the BioPince Ultra Full Core Biopsy Instrument, SuperCore Semi-Automatic, Tru-Core Automatic, and Pro-Mag Ultra Biopsy Instruments. This introduction solidifies Argon’s standing as a premier supplier of soft tissue biopsy devices, concurrently improving patient outcomes.

Which Key Players Are Driving Competition In The Skin Biopsy Market?

Major companies operating in the skin biopsy market are AccuTec Inc., Delasco, KAI Medical, Medline Industries, Becton Dickinson and Company, Merit Medical Systems, Cook Medical, Hologic, Olympus Corporation, KARL STORZ, Richard Wolf, ConMed, Integra LifeSciences, Paramount Surgimed, Sklar Instruments, Hu-Friedy, Aesculap, World Precision Instruments, Miltex, Integra Miltex

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Skin Biopsy Market?

North America was the largest region in the skin biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Skin Biopsy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28330&type=smp

Browse Through More Reports Similar to the Global Skin Biopsy Market 2026, By The Business Research Company

Liquid Biopsy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Biopsy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Skin Biopsy Market Size Likely To Evolve From 2025 Through 2034?

The skin biopsy market has experienced strong growth in recent years. It is anticipated to expand from $1.72 billion in 2024 to $1.86 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.4%. This historical growth can be attributed to the increasing prevalence of skin cancer and chronic skin disorders, a heightened awareness of early disease detection, the adoption of punch biopsy as a standard diagnostic tool, the expansion of hospital and clinic infrastructure, and supportive government initiatives for cancer screening programs.

The skin biopsy market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $2.54 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.1%. The expansion during this projection period is primarily driven by an escalating need for less invasive diagnostic methods, the incorporation of artificial intelligence into biopsy evaluations, an expanding older demographic susceptible to skin conditions, investments in healthcare sectors within developing nations, and the proliferation of teledermatology and virtual consultation offerings. Key developments expected within this forecast timeframe encompass a move towards digital pathology systems, the embrace of less invasive options such as liquid biopsy, customized treatment strategies based on biopsy outcomes, partnerships between medical device manufacturers and healthcare organizations, and the creation of easily portable and user-friendly biopsy instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28330&type=smp

What Are The Main Drivers Boosting The Skin Biopsy Industry’s Expansion?

The increasing occurrence of skin conditions is anticipated to drive the expansion of the skin biopsy market in the future. Skin disorders encompass various conditions impacting the skin’s structure, function, or look, frequently leading to symptoms like inflammation, irritation, or unusual growths. These include acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts, and skin cancer. The frequency of skin disorders is growing, attributed to increased environmental pollution, which can harm the skin barrier and provoke inflammatory or allergic responses. Skin biopsy assists in diagnosing skin disorders by supplying precise tissue samples for microscopic analysis, facilitating early detection of conditions like infections, inflammatory diseases, and cancers, thereby enhancing treatment results and patient well-being. For example, in 2023, Cancer Australia, an Australia-based government agency, reported around 8,257 new diagnoses of melanoma of the skin, representing 2.6% of all cancer-related deaths. Consequently, the growing incidence of skin disorders is boosting the expansion of the skin biopsy market. Increased spending on healthcare is projected to drive the expansion of the skin biopsy market in the coming years. Healthcare expenditure denotes the overall financial outlay on medical services, treatments, facilities, research, and public health programs aimed at sustaining or enhancing health results. The growing need for healthcare spending stems from the increasing occurrence of chronic illnesses, which necessitate prolonged and expensive treatments. Increased healthcare spending promotes the uptake of skin biopsy procedures by making advanced diagnostic technologies more accessible and broadening dermatology services. This facilitates early and precise diagnosis of skin disorders, contributing to improved patient outcomes and greater healthcare efficiency. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure experienced a 5.6% rise in nominal terms in 2023, marking a 0.9% growth compared to 2022. Thus, the escalation in healthcare spending is propelling the growth of the skin biopsy market.

What Are The Leading Segments Analyzed In The Skin Biopsy Market?

The skin biopsy market covered in this report is segmented as

1) By Type Of Biopsy: Excisional Biopsy, Incisional Biopsy, Punch Biopsy, Shave Biopsy, Needle Biopsy

2) By Procedure Type: Surgical Biopsy, Imageguided Biopsy, Dermatoscopic Biopsy, Endoscopic Biopsy

3) By Application: Dermatology, Oncology, Pathology, Clinical Research, Cosmetic Procedures

4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories, Research Institutions, Dermatology Clinics

Subsegments:

1) By Excisional Biopsy: Full-Thickness Excision, Elliptical Excision, Saucerization

2) By Incisional Biopsy: Wedge Biopsy, Longitudinal Biopsy, Keyhole Biopsy

3) By Punch Biopsy: 2 Millimeter (mm) Punch, 3-4 Millimeter (mm) Punch, Greater Than Or Equal To (=) 5 Millimeter (mm) Punch

4) By Shave Biopsy: Tangential Shave, Saucerization Shave, Curved Blade Shave

5) By Needle Biopsy: Fine-Needle Aspiration Biopsy (FNAB), Core Needle Biopsy, Vacuum-Assisted Needle Biopsy

Which Key Market Players Are Investing In Expansion And Innovation Of Skin Biopsy Market?

Major companies operating in the skin biopsy market are Olympus Corporation, Sysmex Corporation, Bio-Rad Laboratories, Exact Sciences Corporation, Cardinal Health Inc., Merit Medical Systems Inc., Abbott Laboratories, Danaher Corporation, Philips Healthcare, Becton, Dickinson and Company (BD), Hologic Inc., Cook Medical, Leica Biosystems Nussloch GmbH, AccuTec Inc., MedicalExpo brands, Delasco, Paramount Surgimed Ltd., Neoteryx, Innovia Medical, and World Precision Instruments.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/skin-biopsy-global-market-report

How Is Skin Biopsy Market Demand Varying Across Different Regions?

North America was the largest region in the skin biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in skin biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Skin Biopsy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28330&type=smp

Browse Through More Reports Similar to the Global Skin Biopsy Market 2025, By The Business Research Company

Skin Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report

Liquid Biopsy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Medical Skin Markers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-skin-markers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model